Improving Low-Income Access to Prescription Drugs Act of 2019

Summary

Improving Low-Income Access to Prescription Drugs Act of 2019 This bill provides statutory authority for the Centers for Medicare & Medicaid Services transition program under the Medicare prescription drug benefit for limited-income, newly eligible individuals (i.e., individuals who are eligible for subsidies and have not yet enrolled in, or whose coverage has not yet taken effect under, a Medicare or Medicare Advantage prescription drug plan). The program's coverage provides immediate access to covered drugs at the point of sale as soon as the individual becomes eligible for subsidies; coverage also applies retroactively for dual eligible individuals and for individuals who receive benefits under the Supplemental Security Income program.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 28 May 2019

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 28 May 2019

   Introduced

   Introduced in House

   Source: IntroReferral

3. 28 May 2019

   Introduced

   Introduced in House

   Source: IntroReferral

4. 29 May 2019

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

5. 4 June 2019

   Committee

   Subcommittee Hearings Held.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 28 May 2019 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 28 May 2019

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 28 May 2019

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 28 May 2019

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Olson, Pete [R-TX-22] · R · Sponsor
• Rep. Barragán, Nanette Diaz [D-CA-44] · D · Sponsor
• Rep. Marchant, Kenny [R-TX-24] · R · Sponsor
• Rep. Lewis, John [D-GA-5] · D · Sponsor
• · hsif00 · Standing
• · hswm00 · Standing

Related records

• related to → Lower Costs, More Cures Act of 2019
• related to ← Improving Low Income Access to Prescription Drugs Act of 2019
• related to ← BETTER Act of 2019
• related to ← Prescription Drug Pricing Reduction Act of 2019
• related to ← Lower Costs, More Cures Act of 2019
• related to ← Prescription Drug Pricing Reduction Act of 2020